Our Helios CD4 analyzer would enable CD4 test results to be rapidly obtained using a drop of blood in a POC setting, which can greatly decrease the time delay from diagnosis to initiation of the ART and thus reduce mortality from HIV/AIDS. This evidence concerns the gene CD4 and AIDS.